Rescula as an alternative therapy for beta-blockers with long-term drift effect in glaucoma patients

Kaohsiung Journal of Medical Sciences

Volumn 22, Issue 6, 2006, Pages 266-270

  Chen, Chang Lin ^a   Tseng, Hang Yi ^a   Wu, Kwou Yeung ^a,b,c  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

Author keywords

Glaucoma; Intraocular pressure; Rescula; Visual field

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; UNOPROSTONE ISOPROPYL ESTER;

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; MALE; NEUROPROTECTION; OPEN ANGLE GLAUCOMA; PERIMETRY; QUANTITATIVE ANALYSIS; TONOMETRY; TREATMENT OUTCOME; VISUAL FIELD DEFECT;

EID: 33749464082     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70310-9     Document Type: Article

References (22)

1. Quigley HA. Recognizing structural damage to the optic nerve head and nerve fiber layer in glaucoma (letter). Am J Ophthalmol 1998;125:563 (discussion 564-5).
2. Orgül S, Gugleta K, Flammer J. Physiology of perfusion as it relates to the optic nerve head. Surv Ophthalmol 1999;43(Suppl 1):S17-26.
3. Anderson DR. Introductory comments on blood flow autoregulation in the optic nerve head and vascular risk factors in glaucoma. Surv Ophthalmol 1999;43(Suppl 1):S5-9.
4. Flammer J, Haefliger IO, Orgül S, et al. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma 1999;8:212-19.
5. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res 2001;20:319-49.
6. Schmidt KG, Klingmüller V, von Rückmann A, et al. Retrobulbäre und chorioidale Hämodynamik bei Hochdruckund Normaldruckglaukom. In: Schmidt KG, Pillunat LE, eds. Fortbildung glaukom. Stuttgart: Enke, 2000:103-14.
7. Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs 2000;59:411-34.
8. Azuma I, Masuda K, Kitazawa Y, et al. Double masked comparative study of UF-021 and Timolol ophthalmic solutions in patients with primary open angle glaucoma or ocular hypertension. Jpn Ophthalmol 1993;37:514-25.
9. Azuma I, Masuda K, Kitazawa Y, et al. Long term study of UF-201 ophthalmic solution in patients with primary open angle glaucoma or ocular hypertension. Atarashii Ganka (J Eye) 1994;11:1435-44.
10. Azuma I. Clinical evaluation of UF-021 ophthalmic solution in glaucoma patients refractory to maximum tolerable therapy. J Jpn Ophthalmol Soc 1993;97:232-8.
11. Tanigichi T, Haque MSR, Sugiyama K, et al. Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug in rabbits. J Ocul Pharmacol 1996;12:489-98.
12. Sugiyama T, Azuma I. Effect of UF-021 on optic nerve head circulation in rabbits. Jpn J Ophthalmol 1995;39:124-9.
13. Questel I, Pages C, Lambrou GN, et al. Effects of unoprostone isopropyl in ocular blood flow decrease induced by systemic vasoconstrictor administration in cynomolgus monkeys (abstract). Invest Ophthalmol Vis Sci 2000;41:S560.
14. Yu DY, Su EN, Cringle SJ, et al. Comparison of the vasoactive effects of the docosanoid unoprostone and selected prostanoids on isolated perfused retinal arterioles. Invest Ophthalmol Vis Sci 2001;42:1499-504.
15. Ogo T. Effect of isopropyl unoprostone on choroidal circulation-changes in choroidal blood flow and intraocular pressure with topical application. Ganki 1996;47:268-72.
16. Kojima S, Sugiyama T, Azuma I, et al. Effect of topically applied isopropyl unoprostone on microcirculation in the human ocular fundus evaluated with a laser speckle microcirculation analyser. Nippon Ganka Gakkai Zasshi 1997;101:605-10.
17. Makimoto Y, Sugiyama T, Kojima S, et al. Long-term effect of topically applied isopropyl unoprostone on microcirculation in the choroid-retina. Nippon Ganka Gakkai Zasshi 2000;104:39-43.
18. Nishi A, Emi K, Ito Y, et al. The change of ocular blood flow after topical instillation of unoprostone eye drops (abstract). Invest Ophthalmol Vis Sci 1997;38:3600.
19. LaFuente MP, Mayor-Torroglosa S, Villagas-Perez M, et al. Retinal ganglion cell survival after transient ligation of the ophthalmic vessels and administration of unoprostone isopropyl (abstract). Invest Ophthalmol Vis Sci 2000;41:S15.
20. Hayami K, Unoki K. Photoreceptor protection against constant light-induced damage by isopropyl unoprostone, a prostaglandin F2a metabolite-related compound. Ophthalmic Res 2001;33:203-9.
21. Hiida Y, Kishimoto N, Deguchi T. Protective effects against light damage to the photoreceptor by topical application with isopropyl unoprostone ophthalmic solution (abstract). Invest Ophthalmol Vis Sci 1999;40:S953.
22. Marcheselli VL, DeCoster MA, Campbell Z, et al. Neuroprotection by unoprostone, but not by latanoprost, against glutamate-stimulated calcium influx and cell death in retinal ganglion cells (abstract). Invest Ophthalmol Vis Sci 2001;42:S750.